Tenet Healthcare Corporation (NYSE: THC) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $23.2B. The Maz Rating grades it against the other companies in its sector.
Tenet Healthcare Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $291.54, Tenet Healthcare Corporation trades at 8.4x trailing earnings, 1.0x sales and 4.3x book value, with an EV/EBITDA of 5.7. Over the last twelve months it generated about $22.8B of revenue and $2.8B of net income. It runs a gross margin of 29.4%, an operating margin of 19.8% and a net margin of 12.7%. It shows return on equity of 60.6%, return on invested capital of 13.8% and a free cash flow yield of 14.3%. On the balance sheet: a debt-to-equity ratio of 2.43 and a current ratio of 1.58. Over the past 52 weeks the share price ranged from $157.58 to $301.44, with a beta of 1.20.
Tenet Healthcare Corporation does not currently pay a dividend.
32 Wall Street analyst ratings cover the stock: 26 Buy and 6 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Tenet Healthcare Corporation (THC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 59.7% / 30% · (Cash+Inv) / Mkt Cap (36m) 12.0% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 59.7% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 12.0% / 33% · Receivables / Mkt Cap (36m) 19.2% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 59.7% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 12.0% / 33.33% · Receivables / Mkt Cap (24m) 19.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 42.9% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 8.68% / 33.33% · Receivables / Avg Assets (4Q) 9.78% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 41.9% / 33.33% · (Cash+ST Inv) / Total Assets 8.46% / 33.33% · (Cash+Recv) / Total Assets 22.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Tenet Healthcare Corporation (THC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Tenet Healthcare Corporation is over the AAOIFI limit on Debt / Mkt Cap (36m).
Tenet Healthcare Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.